Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - BRISTOL MYERS SQUIBB CO | s001154x1_8k.htm |
Exhibit 99.1
2015: Leading in Immuno-Oncology Strong US commercial execution 1 Total IO Market – Weekly IMS DDD + Xponent Yervoy Opdivo BMS I-OPortfolio Keytruda Note: This information is an estimate derived from the use of information under license from the following IMS Health information services: Xponent & DDD weekly dollars, for the period of 1/2/2015 through 12/31/2015. IMS expressly reserves all rights, including rights of copying, distribution and republication.